ALL-HEART: No Benefit of Allopurinol in Ischemic Heart Disease
Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was 'definitively neutral' in patients with heart disease but no gout.
Medscape Medical News
source https://www.medscape.com/viewarticle/979859?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/979859?src=rss
Comments
Post a Comment